Misplaced Pages

Mast cell stabilizer

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Category of pharmaceutical drugs

Cromolyn
Nedocromil

Mast cell stabilizers are medications used to prevent or treat certain allergic disorders. They block mast cell degranulation, stabilizing the cell and thereby preventing the release of histamine and related mediators. One suspected pharmacodynamic mechanism is the blocking of IgE-regulated calcium channels. Without intracellular calcium, the histamine vesicles cannot fuse to the cell membrane and degranulate.

As inhalers they are used to treat asthma, as nasal sprays to treat hay fever (allergic rhinitis) and as eye drops for allergic conjunctivitis. Finally, in oral form, they are used to treat the rare condition of mastocytosis.

Examples

Mast cell stabilizer medications include:

Research

The following substances are studied on their potential mast cell stabilizing effects, but the current results are inconclusive:

References

  1. ^ Finn DF, Walsh JJ (September 2013). "Twenty-first century mast cell stabilizers". Br J Pharmacol. 170 (1): 23–37. doi:10.1111/bph.12138. PMC 3764846. PMID 23441583.
  2. Castillo M, Scott NW, Mustafa MZ, Mustafa MS, Azuara-Blanco A (2015). "Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis". Cochrane Database Syst Rev. 2015 (6): CD009566. doi:10.1002/14651858.CD009566.pub2. hdl:2164/6048. PMC 10616535. PMID 26028608.
  3. Castells M, Butterfield J (April 2019). "Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management". J Allergy Clin Immunol Pract. 7 (4): 1097–1106. doi:10.1016/j.jaip.2019.02.002. PMID 30961835.
  4. ^ Chadwick SJ (15 May 2009). "Principles of Allergy Management". Managing the Allergic Patient. pp. 19–72. doi:10.1016/B978-141603677-7.50006-6. ISBN 978-1-4160-3677-7. Sodium cromoglycate (cromolyn sodium) has now been available in an intranasal format OTC for almost 10 years Nedocromil is much more potent Other ophthalmic mast cell stabilizers include cromolyn sodium, ketotifen, and pemirolast, and topical antihistamines such as olopatadine also demonstrate mast-cell stabilizing effects. Cromolyn sodium is also used as an oral preparation for the treatment of mastocytosis and has been used off-label in the management of food allergy
  5. "Mast cell stabilizers". drugs.com. Retrieved 2 April 2023.
  6. ^ Zhang L, Song J, Hou X (April 2016). "Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside". J Neurogastroenterol Motil. 22 (2): 181–92. doi:10.5056/jnm15137. PMC 4819856. PMID 26755686.
  7. Nwaru BI, Dhami S, Sheikh A (2017). "Idiopathic Anaphylaxis". Curr Treat Options Allergy. 4 (3): 312–319. doi:10.1007/s40521-017-0136-2. PMC 5569651. PMID 28890861.
  8. El-Alali EA, Abukhiran IM, Alhmoud TZ (July 2021). "Successful use of montelukast in eosinophilic gastroenteritis: a case report and a literature review". BMC Gastroenterol. 21 (1): 279. doi:10.1186/s12876-021-01854-x. PMC 8265096. PMID 34238222.
  9. ^ Feuille EJ, Phipatanakul W, Permaul P (2022). "Conventional medications for the treatment of allergic rhinitis and conjunctivitis". Allergic and Immunologic Diseases. pp. 1077–1109. doi:10.1016/B978-0-323-95061-9.00038-2. ISBN 978-0-323-95061-9. Evidence is insufficient to compare the efficacy of available ocular mast cell stabilizers (cromolyn, lodoxamide, nedocromil)
  10. Lui ZQ, Lii XX, Qui ZQ, Yu Y, Li MG (2017). "Vitamin D contributes to mast cell stabilization". Allergy. 72 (8): 1184–1192. doi:10.1111/all.13110. PMID 27998003. S2CID 4643742.
  11. Weng Z, Zhang B, Asadi S, Sismanopoulos N, Butcher A, Fu X, et al. (28 March 2012). "Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans". PLOS ONE. 7 (3): e33805. Bibcode:2012PLoSO...733805W. doi:10.1371/journal.pone.0033805. PMC 3314669. PMID 22470478.
Drugs for obstructive airway diseases: asthma/COPD (R03)
Adrenergics, inhalants
Short-acting β2 agonists
Long-acting β2 agonists
Ultra-long-acting β2 agonists
Other
Glucocorticoids
Anticholinergics/
muscarinic antagonist
Mast cell stabilizers
Xanthines
Eicosanoid inhibition
Leukotriene antagonists
Arachidonate 5-lipoxygenase inhibitors
Thromboxane receptor antagonists
Non-xanthine PDE4 inhibitors
Others/unknown
Combination products
Decongestants and other nasal preparations (R01)
Topical
Sympathomimetics, plain
Antiallergic agents,
excluding corticosteroids
Corticosteroids
Other nasal preparations
Combination products
Systemic use:
Sympathomimetics


Stub icon

This drug article relating to the respiratory system is a stub. You can help Misplaced Pages by expanding it.

Categories: